{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T04:01:56Z","timestamp":1770523316931,"version":"3.49.0"},"reference-count":26,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T00:00:00Z","timestamp":1660176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Sciences and Engineering Research Council of Canada","award":["NSERC, RGPIN-2017-05508"],"award-info":[{"award-number":["NSERC, RGPIN-2017-05508"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Premature death due to heart failure is a major health problem. Taurine is a non-essential amino acid that has received much attention. However, although many studies have been carried out on the beneficial effects of taurine in cardiac pathophysiology, no studies have investigated the effect of taurine treatment on the development of hereditary cardiomyopathy (HCM) associated with hypertrophy, heart failure, and early death. This study aims to verify whether short-term treatment (20 days) with taurine in tap water prevents the development of hypertrophy and premature death in hereditary cardiomyopathy of the hamster (HCMH) of the line UM-X7.1 and if its effect is sex-dependent. Our results show that treatment for 20 days with taurine (250 mg\/kg\/day or 25 mg\/animal\/day) during the development of the hypertrophic phase (220 days old) significantly decreased (p &lt; 0.01) the heart weight to body weight ratio in male HCMHs without affecting the female. During the 20 days (220\u2013240 days old), there were nearly 40% premature deaths in non-treated males HCMHs and 50% in female HCMHs. Treatment for 20 days wholly and significantly prevented early death in both males and females HCMHs. Our results demonstrate that short-term treatment with taurine prevents the development of cardiac hypertrophy associated with HCM in a sex-dependent manner; however, it prevents early death in a sex-independent fashion. Our results suggest that taurine supplementation could be used to treat HCM.<\/jats:p>","DOI":"10.3390\/nu14163287","type":"journal-article","created":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T21:15:05Z","timestamp":1660252505000},"page":"3287","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Short-Communication: Short-Term Treatment with Taurine Prevents the Development of Cardiac Hypertrophy and Early Death in Hereditary Cardiomyopathy of the Hamster and Is Sex-Dependent"],"prefix":"10.3390","volume":"14","author":[{"given":"Ghassan","family":"Bkaily","sequence":"first","affiliation":[{"name":"Department of Immunology and Cell Biology, Faculty of Medicine and Health Sciences, Universit\u00e9 de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanick","family":"Simon","sequence":"additional","affiliation":[{"name":"Department of Immunology and Cell Biology, Faculty of Medicine and Health Sciences, Universit\u00e9 de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Normand","sequence":"additional","affiliation":[{"name":"Department of Immunology and Cell Biology, Faculty of Medicine and Health Sciences, Universit\u00e9 de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley","family":"Jazzar","sequence":"additional","affiliation":[{"name":"Department of Immunology and Cell Biology, Faculty of Medicine and Health Sciences, Universit\u00e9 de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Houssein","family":"Najibeddine","sequence":"additional","affiliation":[{"name":"Department of Immunology and Cell Biology, Faculty of Medicine and Health Sciences, Universit\u00e9 de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0817-3160","authenticated-orcid":false,"given":"Abdelouahed","family":"Khalil","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Medicine and Health Sciences, Universit\u00e9 de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Jacques","sequence":"additional","affiliation":[{"name":"Department of Immunology and Cell Biology, Faculty of Medicine and Health Sciences, Universit\u00e9 de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,8,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"128","DOI":"10.2174\/1573403X11309020006","article-title":"Heart Failure in North America","volume":"9","author":"Blair","year":"2013","journal-title":"Curr. Cardiol. Rev."},{"key":"ref_2","first-page":"e2","article-title":"American Heart Association Statistics Committee and Stroke Statistics Subcommittee. 2012. Heart disease and stroke statistics--2012 update: A report from the American Heart Association","volume":"125","author":"Roger","year":"2012","journal-title":"Circulation"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Ontiveros, E.S., Whelchel, B.D., Yu, J., Kaplan, J.L., Sharpe, A.N., Fousse, S.L., Crofton, A.E., Fascetti, A.J., and Stern, J.A. (2020). Development of plasma and whole blood taurine reference ranges and identification of dietary features associated with taurine deficiency and dilated cardiomyopathy in golden retrievers: A prospective, observational study. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0233206"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/ajcn\/61.5.1115","article-title":"Plasma and platelet taurine are reduced in subjects with insulin-dependent diabetes mellitus: Effects of taurine supplementation","volume":"61","author":"Franconi","year":"1995","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1023\/B:NERE.0000010443.05899.2f","article-title":"Is taurine beneficial in reducing risk factors for diabetes mellitus?","volume":"29","author":"Franconi","year":"2004","journal-title":"Neurochem. Res."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Jazzar, A., Jacques, D., and Bkaily, G. (2021). Insulin-Induced Cardiomyocytes Hypertrophy That Is Prevented by Taurine via \u03b2-alanine-Sensitive Na+-Taurine Symporter. Nutrients, 13.","DOI":"10.3390\/nu13113686"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"225","DOI":"10.4062\/biomolther.2017.251","article-title":"Effects and Mechanisms of Taurine as a Therapeutic Agent","volume":"26","author":"Schaffer","year":"2018","journal-title":"Biomol. Ther."},{"key":"ref_8","first-page":"57","article-title":"The potential health benefits of taurine in cardiovascular disease","volume":"13","author":"Xu","year":"2008","journal-title":"Exp. Clin. Cardiol."},{"key":"ref_9","first-page":"293","article-title":"Role of taurine in the vasculature: An overview of experimental and human studies","volume":"1","author":"Abebe","year":"2011","journal-title":"Am. J. Cardiovasc. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/978-1-4899-0182-8_28","article-title":"Modulation of Ca2+ and Na+ transport by taurine in heart and vascular smooth muscle","volume":"403","author":"Bkaily","year":"1996","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1006879918371","article-title":"Modulation of cytosolic and nuclear Ca2+ and Na+ transport by taurine in heart cells","volume":"170","author":"Bkaily","year":"1997","journal-title":"Mol. Cell. Biochem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1023\/A:1006806925739","article-title":"Taurine indirectly increases [Ca]i by inducing Ca2+ influx through the Na+-Ca2+ exchanger","volume":"188","author":"Bkaily","year":"1998","journal-title":"Mol. Cell. Biochem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1139\/cjpp-2019-0313","article-title":"Taurine and cardiac disease: State of the art and perspectives","volume":"98","author":"Bkaily","year":"2020","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1139\/cjpp-2017-0265","article-title":"Na+-H+ exchanger and proton channel in heart failure associated with Becker and Duchenne muscular dystrophies","volume":"95","author":"Bkaily","year":"2017","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/mus.880050105","article-title":"Hereditary polymyopathy and cardiomyopathy in the Syrian hamster. I. Progression of heart and skeletal muscle lesions in the UM-X7.1 line","volume":"5","author":"Jasmin","year":"1982","journal-title":"Muscle Nerve"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1139\/cjpp-2015-0107","article-title":"Na+-H+ exchanger inhibitor prevents early death in hereditary cardiomyopathy","volume":"93","author":"Bkaily","year":"2015","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.yjmcc.2005.01.003","article-title":"NHE-1-dependent intracellular sodium overload in hypertrophic hereditary cardiomyopathy: Prevention by NHE-1 inhibitor","volume":"38","author":"Chahine","year":"2005","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0169-328X(98)00208-3","article-title":"Discrete distribution of the neuropeptide Y Y5 receptor gene in the human brain: An in situ hybridization study","volume":"61","author":"Jacques","year":"1998","journal-title":"Mol. Brain Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1291\/hypres.24.453","article-title":"Distribution of twenty-four hour urinary taurine excretion and association with ischemic heart disease mortality in 24 populations of 16 countries: Results from the WHO-CARDIAC study","volume":"24","author":"Yamori","year":"2001","journal-title":"Hypertens Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.yrtph.2008.01.004","article-title":"Risk assessment for the amino acids taurine, l-glutamine and l-arginine","volume":"50","author":"Shao","year":"2008","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/1423-0127-17-S1-S4","article-title":"Taurine and the renal system","volume":"17","author":"Chesney","year":"2010","journal-title":"J. Biomed. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/apha.12365","article-title":"Physiological role of taurine\u2014From organism to organelle","volume":"213","author":"Lambert","year":"2014","journal-title":"Acta Physiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s12967-015-0610-1","article-title":"Taurine: The appeal of a safe amino acid for skeletal muscle disorders","volume":"13","author":"Pierno","year":"2015","journal-title":"J. Transl. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s11010-018-3440-7","article-title":"Endocardial endothelial cell hypertrophy takes place during the development of hereditary cardiomyopathy","volume":"453","author":"Jacques","year":"2019","journal-title":"Mol. Cell. Biochem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1139\/y03-046","article-title":"Angiotensin II and its receptors in human endocardial endothelial cells: Role in modulating intracellular calcium","volume":"81","author":"Jacques","year":"2003","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00424-022-02669-9","article-title":"Hypotension in hereditary cardiomyopathy","volume":"474","author":"Jacques","year":"2022","journal-title":"Pflug. Arch."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/14\/16\/3287\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:07:16Z","timestamp":1760141236000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/14\/16\/3287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,11]]},"references-count":26,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["nu14163287"],"URL":"https:\/\/doi.org\/10.3390\/nu14163287","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,11]]}}}